Amneal Pharmaceuticals to add 200 jobs at its Brookhaven factory

A drug manufacturer plans to add 200 jobs to its workforce of 800 people in Brookhaven Town to make medical devices for another company, executives said this week. Amneal Pharmaceuticals Inc. will ... Read More

Amneal Pharmaceuticals to close LI facility, eliminate 220 jobs

Drugmaker Amneal Pharmaceuticals Inc. plans to close its Hauppauge factory next year, eliminating 220 jobs, executives announced Wednesday. Read More

Amneal planning $60M Yaphank expansion for July

Amneal Pharmaceuticals hopes to break ground on a 325,000 square-foot expansion project in July to be added to its 120,000 square-foot facility in Yaphank. Read More

New Jersey drugmaker to cut 220 New York jobs - Becker's Hospital ...

Amneal Pharmaceuticals, a New Jersey generic drugmaker will close its factory in Hauppauge, N.Y., next year, eliminating 220 jobs, according to Newsday. Read More

Amneal the latest drugmaker to recall ranitidine products

Bridgewater, N.J.-based Amneal Pharmaceuticals is the latest company to recall its ranitidine products after discovering they contain unacceptable levels of a possible carcinogen. Read More

Amneal Pharmaceuticals Breaks Above 200-Day Moving Average - Nasdaq

In trading on Tuesday, shares of Amneal Pharmaceuticals Inc (Symbol: AMRX) crossed above their 200 day moving average of $8.13, changing hands as high as $8.17 per share. Amneal Pharmaceuticals ... Read More

FDA cites another Indian drugmaker; Amneal and Intrexon work on new API;

> New Jersey-based generic drugmaker Amneal Pharmaceuticals has a new deal with Intrexon to develop an improved production process for a complex active pharmaceutical ingredient. Read More

Amneal's $83M Saol Acquisition Deal Expands Its Neurology Presence Into ...

The acquisition expands Amneal's commercial institutional and specialty portfolio in neurology while adding commercial infrastructure in advance of its entry into the biosimilar institutional market. Read More